Profile
Michael Soumas focuses his practice on corporate securities matters, representing both domestic and foreign companies in a full range of general corporate and securities matters, with a focus on navigating the process of capital raising, including initial public offerings (IPOs), follow-on offerings, shelf takedowns, private placements in public equities (PIPEs), as well as SEC reporting and compliance and corporate governance matters.
Michael advises clients on a wide variety of securities laws and governance matters, including drafting and reviewing annual, periodic and current reports and proxy statements, compliance with SEC/stock exchange rules and board meeting minutes, as well as with respect to day-to-day operational matters, including contract review, covenant compliance and investor communications. Michael also represents banks and funds in capital markets transactions, including underwritten public offerings, at-the-market facilities, equity line programs and PIPEs. Michael works with many Israeli tech companies in a myriad of areas including life sciences, defense, tech, pharma and others.
Prior to joining Greenberg Traurig, Michael served as vice president and counsel at a global investment bank, providing legal advice on equity derivative, margin loan and structured finance transactions.
Concentrations
- Securities and capital markets
- Public and private offerings, including IPOs
- SEC reporting and corporate governance compliance
- Dual listings and American depositary facilities
- Equity line and ATM facilities
- Share exchange transactions
- Equity derivatives and margin loans
- Pharma, medical service, digital health and other life science
- Israel
- Greece
Áreas de Atuação
Experiência
- Ongoing representation of several Nasdaq and NYSE public companies.
- Represented an Israeli video optimization technology and solutions in their initial public offering (IPO) on the Nasdaq and follow-on public offering.
- Represented an Israel company that is a global leader in vision and light control technologies in their IPO on the Nasdaq.
- Represented an Israeli regenerative medicine company in their IPO on the New York Stock Exchange.
- Represented an Israeli company that is a leading innovator in alternative proteins and 3D printing technologies in multiple transactions, including a follow-on public offering of American Depositary Shares and warrants, warrant inducement transaction, private investment in public equity (PIPE), equity line facility, at-the-market sale (ATM) facility.
- Represented an Israeli-based company which develops systems for the prevention of strokes in multiple transactions, including PIPEs and ATM facility.
- Represented an Israeli technology company that seeks to revolutionize railway safety and the data-related market in multiple transactions, including a PIPE, equity line facility, ATM facility and convertible loan facility.
- Represented an Israeli technology company that develops and commercializes advanced transportation safety solutions in establishing an equity line facility.
- Represented an Israeli aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry in multiple transactions, including IPO on the Nasdaq, a PIPE and registered direct offerings.
- Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in multiple transactions, including a warrant inducement transaction, ATM facility and registered direct offering.
- Represented an Israeli company that is a global leader in connected home ultrasound technology in the dual listing of its ordinary shares on the Nasdaq.
- Represented an Israeli-based advanced technology company in multiple transactions, including the uplisting of its common stock to the Nasdaq, PIPEs and convertible loan facility.
- Represented an Israeli-based biotech company in multiple transactions, including the uplisting of its common shares to Nasdaq, registered direct offerings and convertible loan facility.
- Represented an Israeli biotechnology company in multiple transactions, including their IPO on the Nasdaq and PIPE.
- Represented an Israeli-based company that is a provider of cybersecurity and robust solutions for drones and robotics in multiple transactions, including its registered direct offering and ATM facility.
- Represented an Israeli-based company that is a leader in AI-powered visual sensing technologies in the uplisting of its common stock to the Nasdaq.
- Represented an Israel late-clinical stage biotechnology company in multiple transactions, including registered direct offering, PIPE, ATM facility and equity line facility.
- Represented an Israeli clinical-stage biopharmaceutical company in multiple transactions, including follow-on public offering, equity line facility, ATM facility and establishment of a digital asset management strategy.
- Represented an Israeli biotechnology company that is listed on the New York Stock Exchange on multiple transactions, including registered direct offerings, follow-on public offering, warrant inducement transactions and ATM facility.
- Represented an Israeli-based clinical stage biotechnology company in multiple transactions, including follow-on public offerings, warrant inducement transactions and ATM facility.
- Represented purchasers in connection with equity line programs.
- Represented investment banks in connection with underwritten public offerings, PIPEs and ATM programs.
- Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that is engaged in developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum-based GPS replacement and quantum atom accuracy solutions.
- Represented an Israeli-based technology company in its strategic acquisition in a share exchange transaction of approximately 30% of the share capital of an Israeli company that designed and manufactures micro-mobility solutions, supporting its continued growth and market‑expansion strategy.
- Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a Spanish technology company that is engaged in delivering size and fit solutions for every stage of the fashion industry’s value chain.
- Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a European SaaS company specializing in AI-powered footwear sizing and fit solutions.
- Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that specializes in developing advanced writing assistance tools that leverage artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) technologies.
- Represented an Israeli technology company that seeks to revolutionize railway safety and the data-related market in its strategic acquisition in a share exchange transaction of 51% of the share capital of an Israeli a cutting-edge quantum computing and AI company.
- Vice President and Counsel, Credit Suisse Securities (USA) LLC, 2014-2022
Reconhecimento & Liderança
- Chambers Global
- Team Member, Corporate/M&A (Desk based Abroad in USA), 2022-2026
- LMG Life Sciences EMEA Awards:
- Shortlisted, Israeli Firm of the Year, 2025
- Shortlisted, Corporate Rising Star, 2024
- LegallyIsrael100
- Team Member, Capital Markets, 2023-2025
- Team Member M&A (Volume & Value), 2022-2025
- Team Member, Hi-Tech, 2022-2025
- Team Member, Banking & Finance, 2022-2025
- Dun's 100 (Israel)
- Recognized, Capital Markets, Notable Law Firm, 2025
- Recognized, International Commercial, Prominent Team, 2022-2025
- Recognized, Hi-Tech, Notable Law Firm, 2022-2025
- BDiCode
- Recognized, Commercial, Prominent Leaders, 2022-2023; 2025
- Recognized, International Commercial, Prominent Leaders, 2022-2025
- Recognized, Capital Markets, Prominent Leaders, 2024-2025
- Recognized, Hi-Tech, Prominent Leaders, 2021-2025
- IFLR1000 (Israel)
- Recognized, Capital Markets: Equity, 2024-2025
Credenciais
-
J.D., cum laude, New York Law School
- Staff Editor, New York Law School Law Review
- John Marshall Harlan Scholar, affiliated with the Center for Business and Financial Law
- B.A.S., Economics, Pennsylvania State University
- New York
- Inglês, Native
- Espanhol, Conversational